Biography
Dr Bristi Basu is an academic consultant in medical oncology in the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, specialising in experimental cancer therapeutics. Her specialist research focus is in hepato-pancreatic-biliary tumours. She trained in Physiological studies and Medicine at Oxford University, gaining Prosser Exhibition scholarships, before undertaking clinical specialty training in Medical Oncology at Cambridge. During this time, she completed a PhD in cancer cell biology and drug discovery at the University of Cambridge, as the Cancer Research UK Gordon Hamilton-Fairley Clinical Research Training Fellow. She has worked as a chief investigator, UK co-ordinating investigator, principal investigator and co-investigator in academic-led and industry-sponsored Phase I, II and III clinical trials, including first-in-human and first-in-class studies. She leads the Cambridge Experimental Cancer Medicine Centre, directs the Cambridge Cancer Trials Centre and co-leads CRUK Cambridge Centre Pancreatic Cancer Programme. She is Chair of the Cancer Research UK Expert Review Panel and Vice-Chair of Cancer Research UK’s Clinical Research Committee. She co-leads the Novel Therapeutics working group in the UK NCRI Pancreatic subgroup and is a member of the Research Strategy Group for Pancreatic Cancer UK, advising the Board of Trustees and Chief Executive on the development and implementation of Pancreatic Cancer UK’s research strategy. She works within the Capacity Building leadership team of Cambridge NIHR Biomedical Research Centre and is Director of Studies for Part 2 medical students at Robinson College, Cambridge.
